logo

For the Inventor, By the Inventor

GB

Topotarget UK Limited

Calculating rank
USPTO Granted Patents = 24

% Expired Patents = 37.5



Forward Citations = 146

Loading Chart...
Loading Chart...

43 inventors (with patents filed for the assignee):

goldMedal Einars Loza (12 out of 18 patents)

silverMedal Ivars Kalvinsh (12 out of 24 patents)

bronzeMedal James Ritchie (11 out of 11 patents)

4.  Paul W Finn (10 out of 10 patents)

5.  Vija Gailite (9 out of 9 patents)

6.  Daina Lolya (7 out of 7 patents)

7.  Clare J Watkins (7 out of 7 patents)

8.  Igor Starchenkov (7 out of 7 patents)

9.  Victor Andrianov (6 out of 10 patents)

10.  Klara Dikovska (6 out of 6 patents)

11.  Henri Lichenstein (5 out of 33 patents)

12.  Maria Rosario Romero-Martin (5 out of 5 patents)

13.  C John Harris (5 out of 5 patents)

14.  James E S Duffy (5 out of 5 patents)

15.  Kamille Dumong Erichsen (4 out of 4 patents)


24 patents:

1. 10799469 - Combination therapies using HDAC inhibitors (2020-10-13),
2. 10285959 - Combination therapies using HDAC inhibitors (2019-05-14),
3. 9980957 - Histone deacetylase (HDAC) inhibitors for the treatment of cancer (2018-05-29),
4. 9957227 - Pharmaceutical formulations of HDAC inhibitors (2018-05-01),
5. 9856211 - Pharmaceutical formulations of HDAC inhibitors (2018-01-02),
6. 9603926 - Histone deacetylase (HDAC) inhibitors for the treatment of cancer (2017-03-28),
7. 8835501 - Pharmaceutical formulations of HDAC inhibitors (2014-09-16),
8. 8828392 - Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent (2014-09-09),
9. 8642809 - Methods of synthesis of certain hydroxamic acid compounds (2014-02-04),
10. 8071620 - Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors (2011-12-06),
11. 7981895 - Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors (2011-07-19),
12. 7880020 - Carbamic acid compounds comprising an amide linkage as HDAC inhibitors (2011-02-01),
13. 7652036 - Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors (2010-01-26),
14. 7629343 - Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors (2009-12-08),
15. 7569724 - Carbamic acid compounds comprising an amide linkage as HDAC inhibitors (2009-08-04),
Company Overview
Topotarget UK Limited is a biopharmaceutical company focused on the development of innovative therapies for cancer treatment. The organization specializes in targeted therapies that aim to improve patient outcomes by addressing specific molecular targets associated with various malignancies. With a commitment to advancing cancer care, Topotarget engages in extensive research and development activities, collaborating with academic institutions and industry partners to bring novel solutions to the market. The company operates primarily within the UK, contributing to the global fight against cancer.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

24 Patents

#31 in

#739 in United Kingdom

#26,701 in the World

GB
GB

Topotarget UK Limited

Forward Citations = 146

43 inventors:

goldMedal Einars Loza (12 out of 18 patents)

silverMedal Ivars Kalvinsh (12 out of 24 patents)

bronzeMedal James Ritchie (11 out of 11 patents)

4.  Paul W Finn (10 out of 10 patents)

5.  Vija Gailite (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Topotarget UK Limited. Retrieved from https://idiyas.com/company/topotarget-uk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…